21, 2024 /PRNewswire/ — Intas Pharmaceuticals Limited (“Intas”) has announced that the Committee for Medicinal Products […] "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod ...

HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...

Bagsværd, Denmark Saturday, September 21, 2024, 15:00 Hrs [IST] ...

Marathon County has produced ginseng for 125 years now. The root can be found in chapsticks, lotions, and medicinal products.

Under the approved guidelines, New Jersey now allows for offerings such as baked goods, chocolates, butters, jams and drinks ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...

Apellis Pharmaceuticals shares are moving lower after the Committee for Medicinal Products for Human Use of the European Medicines Agency confirmed its June 2024 negative opinion following ...

The decision against Syfovre’s approval follows efforts by Apellis to have reviewers reevaluate clinical evidence multiple times and, according to an analyst, will lead to a restructuring of the ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...